Continuous medicine production device

Abstract

The utility model relates to a medicine continuous production device which comprises a box body, a control panel is fixedly installed on the outer surface of the box body, a functional structure is fixedly installed on the outer surface of the right side of the box body, a first box is fixedly installed on the top of the box body, and a functional box is fixedly installed on the top of the box body. A second box is fixedly mounted at the top of the box body, and guide pipes are fixedly mounted at the tops of the first box and the second box. When the drug continuous production device is used, chiral epichlorohydrin is added into the first box, then a mixed drug is added into the second box, when production needs to be conducted, the chiral epichlorohydrin and the mixed drug enter the box through a connecting pipe, then a driving motor is started, and the chiral epichlorohydrin and the mixed drug enter the box through the connecting pipe; the driving motor drives the driving gear to rotate, then drives the driven gear to rotate synchronously and then drives the rotating rod to rotate, and then the rotating rod drives the stirring rod to rotate so that the medicine and the additive can be subjected to a fusion reaction.

Description

Technical Field

[0001] The utility model relates to the technical field of drug production, in particular to a drug continuous production device. Background Art

[0002] From the perspective of the target users, drugs are used by humans to prevent, treat, and diagnose human diseases and purposefully regulate human physiological functions. They have prescribed indications, usage, and dosage requirements. From the perspective of usage, apart from appearance, patients cannot identify their intrinsic quality. Many drugs need to be used under the guidance of a doctor, rather than being decided by the patient. At the same time, the effectiveness of a drug is largely determined by multiple factors such as the method, quantity, and time of use. Misuse of a drug may not only fail to "cure the disease", but may also "cause disease" and even endanger life. Before the drug is sold or taken, the raw materials need to be stirred and subsequently synthesized before they can be put on the market for sale.

[0003] Most of the traditional continuous drug production devices on the existing market are separated into several parts. During the production process, they need to circulate back and forth in several production devices. Harmful gases will be generated during the turnover process, causing pollution to the environment. In addition, when chiral epichlorohydrin is produced, the reaction heat is large and the thermal temperature rises. The existing production devices have poor cooling effects and low working efficiency, which causes troubles for subsequent production and is not conducive to subsequent production. For this reason, we propose a continuous drug production device. Utility Model Content

[0004] In view of the deficiencies in the prior art, the utility model provides a continuous drug production device, which has the advantages of better cooling effect and continuous production, and solves the problem of poor cooling effect of traditional production devices.

[0005] To achieve the above-mentioned purpose, the utility model provides the following technical solutions: a drug continuous production device, comprising a box, a control panel is fixedly installed on the outer surface of the box, a functional structure is fixedly installed on the right outer surface of the box, a No. 1 box is fixedly installed on the top of the box, a functional box is fixedly installed on the top of the box, a No. 2 box is fixedly installed on the top of the box, a conduit is fixedly installed on the top of the No. 1 box and the No. 2 box, a water injection pipe is fixedly installed on the outer surface of the box, a discharge pipe is fixedly installed on the bottom of the box, and four supporting legs are fixedly installed on the bottom of the box;

[0006] The functional structure includes an adding pipe located on the outer surface of the right side of the box body, connecting pipes extending to the interior of the box body are fixedly installed inside the No. 1 box and the No. 2 box, a rotating rod is movably installed on the inner bottom wall of the box body, a cooling chamber is opened inside the box body, a number of stirring rods are fixedly installed on the outer surface of the rotating rod, a scraper is fixedly installed on the outer surface of the stirring rod, a driving motor is fixedly installed on the inner wall of the left side of the functional box, a driving gear is fixedly installed at the output shaft of the driving motor, and a driven gear is fixedly installed on the top of the rotating rod inside the functional box.

[0007] Furthermore, the outer surface of the driving gear is meshed with the outer surface of the driven gear, and a valve is fixedly installed on the outer surface of the adding pipe.

[0008] Furthermore, a solenoid valve is fixedly mounted on the outer surface of the discharge pipe, and the left outer surface of the addition pipe extends to the interior of the cooling chamber.

[0009] Furthermore, the outer surface of the scraper is in contact with the inner wall of the box, and sealing covers are movably installed on the tops of the two conduits.

[0010] Furthermore, the bottom of the rotating rod is movably connected to the inner bottom wall of the box body through a bearing.

[0011] Furthermore, the four supporting legs are respectively located at four corners of the bottom wall of the box body, and a through opening adapted to the outer surface of the rotating rod is opened on the top of the box body.

[0012] Compared with the prior art, the technical solution of this application has the following beneficial effects:

[0013] The drug continuous production device, when in use, adds chiral epichlorohydrin into box No. 1 and then adds mixed medicine into box No. 2; when production is needed, chiral epichlorohydrin and mixed medicine enter the interior of the box through the connecting pipe, and then starts the driving motor, the driving motor drives the driving gear to rotate, and then drives the driven gear to rotate synchronously, and then drives the rotating rod to rotate, and the rotating rod drives the stirring rod to rotate to make the drug itself and the additive to react with each other, accelerate the production of the drug, and generate a lot of heat in the reaction process, by pouring the coolant into the cooling chamber through the adding pipe to help absorb the heat generated when the drug is mixed, ensure that the drug reacts at a suitable temperature, avoid excessive temperature in the inner cylinder, open the solenoid valve after production is completed, so that the drug flows from the discharge pipe to the designated location, and when production is completed, add clean water into the water injection pipe, and the clean water enters the box from the water injection pipe for cleaning, through the above structures, convenient cooling effect can be achieved. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 It is a schematic diagram of the structure of the utility model;

[0015] Figure 2 This is a front cross-sectional view of the functional structure of the utility model;

[0016] Figure 3 The functional structure of the utility model Figure 2 Enlarged view of point A in the middle.

[0017] In the figure: 1. Box body; 2. Control panel; 3. Functional structure; 301. Adding pipe; 302. Connecting pipe; 303. Rotating rod; 304. Cooling chamber; 305. Stirring rod; 306. Scraper; 307. Driving motor; 308. Driving gear; 309. Driven gear; 4. Box No. 1; 5. Functional box; 6. Box No. 2; 7. Conduit; 8. Water injection pipe; 9. Discharge pipe; 10. Support leg. DETAILED DESCRIPTION

[0018] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0019] See also Figure 1-3 A drug continuous production device in this embodiment includes a box body 1, a control panel 2 is fixedly installed on the outer surface of the box body 1, a functional structure 3 is fixedly installed on the right outer surface of the box body 1, a No. 1 box 4 is fixedly installed on the top of the box body 1, a functional box 5 is fixedly installed on the top of the box body 1, a No. 2 box 6 is fixedly installed on the top of the box body 1, and a conduit 7 is fixedly installed on the top of the No. 1 box 4 and the No. 2 box 6, a water injection pipe 8 is fixedly installed on the outer surface of the box body 1, a discharge pipe 9 is fixedly installed on the bottom of the box body 1, and four supporting legs 10 are fixedly installed on the bottom of the box body 1.

[0020] The functional structure 3 includes an adding pipe 301 located on the right outer surface of the box body 1, and the interiors of the No. 1 box 4 and the No. 2 box 6 are fixedly installed with connecting pipes 302 extending to the interior of the box body 1. A rotating rod 303 is movably installed on the inner bottom wall of the box body 1. A cooling chamber 304 is opened inside the box body 1. A number of stirring rods 305 are fixedly installed on the outer surface of the rotating rod 303, and a scraper 306 is fixedly installed on the outer surface of the stirring rod 305. A driving motor 307 is fixedly installed on the left inner wall of the functional box 5, and a driving gear 308 is fixedly installed at the output shaft of the driving motor 307. A driven gear 309 is fixedly installed on the top of the rotating rod 303 inside the functional box 5.

[0021] exist Figure 2In the embodiment, by setting the outer surface of the driving gear 308 and the outer surface of the driven gear 309 to mesh, the rotation of the driving gear 308 can drive the driven gear 309 and the rotating rod 303 to rotate synchronously.

[0022] exist Figure 2 In the embodiment, by extending the adding pipe 301 to the interior of the cooling chamber 304 , the coolant can be introduced into the interior of the cooling chamber 304 through the adding pipe 301 .

[0023] exist Figure 2 In the embodiment, a sealing cover is provided on the top of the conduit 7, so that it is convenient to seal with the conduit 7, thereby achieving a dustproof effect.

[0024] exist Figure 2 In the embodiment, a bearing is provided at the bottom of the rotating rod 303 to be connected to the inner bottom wall of the box body 1, so that a more stable effect can be achieved when the rotating rod 303 rotates.

[0025] In summary, the drug continuous production device, when in use, when using the drug production device, chiral epichlorohydrin is added to the first box 4 and then the mixed agent is added to the second box 6. When production is required, the chiral epichlorohydrin and the mixed agent enter the interior of the box body 1 through the connecting pipe 302, and then the driving motor 307 is started, and the driving motor 307 drives the driving gear 308 to rotate, and then drives the driven gear 309 to rotate synchronously, and then drives the rotating rod 303 to rotate, and the rotating rod 303 drives the stirring rod 305 to rotate to make the drug itself and the added The agent undergoes a fusion reaction to accelerate the production of the drug. A large amount of heat is generated during the reaction. The coolant is poured into the cooling chamber 304 through the adding pipe 301 to help absorb the heat generated when the drug is mixed, thereby ensuring that the drug reacts at a suitable temperature and avoiding excessive temperature in the box 1. After the production is completed, the solenoid valve is opened to allow the drug to flow from the discharge pipe 9 to the designated location. When the production is completed, clean water is added to the water injection pipe 8, and the clean water enters the box 1 from the water injection pipe 8 for cleaning. Through the above structures, convenient cooling can be achieved with better effect.

[0026] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the existence of other identical elements in the process, method, article or device including the elements.

[0027] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A drug continuous production device, comprising a housing (1), characterized in that: A control panel (2) is fixedly mounted on the outer surface of the box (1), a functional structure (3) is fixedly mounted on the right outer surface of the box (1), a No. 1 box (4) is fixedly mounted on the top of the box (1), a functional box (5) is fixedly mounted on the top of the box (1), a No. 2 box (6) is fixedly mounted on the top of the box (1), a guide tube (7) is fixedly mounted on the top of both the No. 1 box (4) and the No. 2 box (6), a water injection pipe (8) is fixedly mounted on the outer surface of the box (1), a discharge pipe (9) is fixedly mounted on the bottom of the box (1), and four supporting legs (10) are fixedly mounted on the bottom of the box (1); The functional structure (3) comprises an addition pipe (301) located on the right outer surface of the box body (1); the interiors of the first box (4) and the second box (6) are fixedly provided with connecting pipes (302) extending to the interior of the box body (1); a rotating rod (303) is movably provided on the inner bottom wall of the box body (1); a cooling chamber (304) is provided inside the box body (1); a plurality of stirring rods (305) are fixedly provided on the outer surface of the rotating rod (303); a scraper (306) is fixedly provided on the outer surface of the stirring rod (305); a driving motor (307) is fixedly provided on the left inner wall of the functional box (5); a driving gear (308) is fixedly provided on the output shaft of the driving motor (307); and a driven gear (309) is fixedly provided on the top of the rotating rod (303) inside the functional box (5).

2. A drug continuous production device according to claim 1, characterized in that: The outer surface of the driving gear (308) is meshed with the outer surface of the driven gear (309), and a valve is fixedly mounted on the outer surface of the adding pipe (301).

3. A drug continuous production device according to claim 1, characterized in that: A solenoid valve is fixedly mounted on the outer surface of the discharge pipe (9), and the left outer surface of the addition pipe (301) extends to the interior of the cooling chamber (304).

4. A drug continuous production device according to claim 1, characterized in that: The outer surface of the scraper (306) is in contact with the inner wall of the box body (1), and sealing covers are movably installed on the tops of the two conduits (7).

5. A drug continuous production device according to claim 1, characterized in that: The bottom of the rotating rod (303) is movably connected to the inner bottom wall of the box body (1) via a bearing.

6. A drug continuous production device according to claim 1, characterized in that: The four supporting legs (10) are respectively located at the four corners of the inner bottom wall of the box body (1), and the top of the box body (1) is provided with a through opening that matches the outer surface of the rotating rod (303).

Images